EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure

Kristian Ujka, Alessandra Pizzuto, Mario Giordano, Francesca Maria Di Muro, Gianpiero Gaio, Maria Giovanna Russo, Berardo Sarubbi, Francesco Meucci, Giuseppe Santoro

EuroIntervention · 2025-08 · 21 (16) · 933-941

DOI: 10.4244/eij-d-24-00856 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift EuroIntervention, 2025-08. Verfasst von Kristian Ujka und 8 weiteren Autor:innen. Beteiligte Einrichtung: 1. Pediatric Cardiology and GUCH Unit, Heart Hospital "G. Pasquinucci", National Research Council-Tuscany Foundation "G. Monasterio", Massa, Italy. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Cardiac Catheterization, Septal Occluder Device, Stroke. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Residual shunt (RS) after transcatheter patent foramen ovale (PFO) closure has been associated with an increased risk of recurrent stroke over long-term follow-up. However, RS prevalence, anatomical characteristics, and treatment strategies are poorly understood. AIMS: This study aimed to assess the prevalence and causes of RS, as well as to evaluate the safety and feasibility of its percutaneous treatment. METHODS: Patients with RS at transcranial Doppler after transcatheter PFO closure in three Italian high-volume centres between 2000 and 2022 were included. The prevalence and anatomical characteristics of RS, its relationship with the original occluding device, and the procedural details of percutaneous treatment were assessed. RESULTS: Among the 2,362 patients who underwent PFO closure, any grade and significant RS were diagnosed in 8.8% and 3.6% of patients, respectively. It was more frequently found after use of the NobleStitch system than after double-disc device implantation (20.0% vs 8.5%; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Foramen Ovale, PatentCardiac CatheterizationSeptal Occluder DeviceStrokeHumansMaleFemaleMiddle AgedPrevalenceTreatment OutcomeAgedAdultItalyUltrasonography, Doppler, TranscranialRetrospective Studies

Autor:innen und Institutionen

  • 1. Pediatric Cardiology and GUCH Unit, Heart Hospital "G. Pasquinucci", National Research Council-Tuscany Foundation "G. Monasterio", Massa, Italy.
  • 2. Pediatric Cardiology and GUCH Unit, "Ospedali dei Colli", "L. Vanvitelli" University of Naples, Naples, Italy.
  • 3. Structural Interventional Cardiology Unit, Careggi University Hospital, Florence, Italy.

Zitieren

APA

Ujka, K., Pizzuto, A., Giordano, M., Di Muro, F. M., Gaio, G., Russo, M. G., Sarubbi, B., Meucci, F., & Santoro, G. (2025). Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure. EuroIntervention, 21(16), 933-941. https://doi.org/10.4244/eij-d-24-00856

Vancouver

Ujka K, Pizzuto A, Giordano M, Di Muro FM, Gaio G, Russo MG, et al. Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure. EuroIntervention. 2025;21(16):933-941. doi:10.4244/eij-d-24-00856

BibTeX
@article{Ujka2025,
  author = {Ujka, Kristian and Pizzuto, Alessandra and Giordano, Mario and Di Muro, Francesca Maria and Gaio, Gianpiero and Russo, Maria Giovanna and Sarubbi, Berardo and Meucci, Francesco and Santoro, Giuseppe},
  title = {Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure},
  journal = {EuroIntervention},
  year = {2025},
  volume = {21},
  number = {16},
  pages = {933--941},
  doi = {10.4244/eij-d-24-00856}
}
Kostenlos starten →